Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

被引：5
|
作者：
Disel, U.
Paydas, S. [1 ]
Yavuz, S.
Karakoc, E.
机构：
[1] Cukurova Univ, Fac Med, Dept Oncol, TR-01330 Adana, Turkey
来源：
CHEMOTHERAPY | 2010年 / 56卷 / 02期
关键词：
Fludarabine; Pulmonary toxicity; Rituximab; CHRONIC LYMPHOCYTIC-LEUKEMIA; INTERSTITIAL PNEUMONITIS; FOLLICULAR LYMPHOMA; PHASE-II; THERAPY; CLL;
D O I：
10.1159/000305255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fludarabine is a nucleoside analogue used in the treatment of low-grade lymphoproliferative disorders and in conditioning regimens of non-myeloablative allogeneic stem cell transplantation. This is a relatively safe drug for clinical use but may cause side effects, some of which may be life-threatening. Here a case of severe pulmonary toxicity associated with fludarabine and a possible contribution of rituximab is presented and the literature reviewed. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [41] Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia
    Souchet, Laetitia
    Levy, Vincent
    Ouzegdouh, Maya
    Tamburini, Jerome
    Delmer, Alain
    Dupuis, Jehan
    Le Gouill, Steven
    Pegourie-Bandelier, Brigitte
    Tournilhac, Olivier
    Boubaya, Marouanne
    Vargaftig, Jacques
    Choquet, Sylvain
    Leblond, Veronique
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (08) : 782 - 786
  • [42] Fludarabine-related pulmonary toxicity - A distinct clinical entity in chronic lymphoproliferative syndromes
    Helman, DL
    Byrd, JC
    Ales, NC
    Shorr, AF
    CHEST, 2002, 122 (03) : 785 - 790
  • [43] Unexpected hematotoxicity associated with a combination of rituximab, fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
    Leo, E
    Scheuer, L
    Kraemer, A
    Kerowgan, M
    Leo, A
    Ho, AD
    BLOOD, 2002, 100 (11) : 301B - 301B
  • [44] Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy
    Garratty, George
    Petz, Lawrence D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (04) : 622 - 623
  • [45] Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma
    Leo, E
    Scheuer, L
    Schmidt-Wolf, IGH
    Kerowgan, M
    Schmitt, C
    Leo, A
    Baumbach, T
    Kraemer, A
    Mey, U
    Benner, A
    Parwaresch, R
    Ho, AD
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (04) : 251 - 257
  • [46] Sirolimus-Associated Pulmonary Toxicity
    Mohamedaly, O.
    Sell, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [47] Pomalidomide-Associated Pulmonary Toxicity
    Icard, Bradley L.
    Singh, Vivek
    Loschner, Anthony L.
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (01) : E143 - E144
  • [48] Irinotecan-associated pulmonary toxicity
    Madarnas, Y
    Webster, P
    Shorter, AM
    Bjarnason, GA
    ANTI-CANCER DRUGS, 2000, 11 (09) : 709 - 713
  • [49] Sirolimus-associated pulmonary toxicity
    Pham, PTT
    Pham, PCT
    Danovitch, GM
    Ross, DJ
    Gritsch, HA
    Kendrick, EA
    Singer, J
    Shah, T
    Wilkinson, AH
    TRANSPLANTATION, 2004, 77 (08) : 1215 - 1220
  • [50] Pulmonary Toxicity Associated with Vaping Marijuana
    Holub, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345